172967-12-3

Basic information

• Product Name: 1,4-Dioxa-8-azaspiro[4.5]decane-6,8-dicarboxylic acid, 6-methyl 8-(phenylmethyl) ester
• CAS NO: 172967-12-3
• Molecular Formula: C17H21NO6
• Molecular Weight: 335.357
• Mol File: 172967-12-3.mol

Chemical Properties

• CAS DataBase Reference: 1,4-Dioxa-8-azaspiro[4.5]decane-6,8-dicarboxylic acid, 6-methyl 8-(phenylmethyl) ester(CAS DataBase Reference)
• NIST Chemistry Reference: 1,4-Dioxa-8-azaspiro[4.5]decane-6,8-dicarboxylic acid, 6-methyl 8-(phenylmethyl) ester(172967-12-3)
• EPA Substance Registry System: 1,4-Dioxa-8-azaspiro[4.5]decane-6,8-dicarboxylic acid, 6-methyl 8-(phenylmethyl) ester(172967-12-3)

Safety Data

• Hazardous Substances Data: 172967-12-3(Hazardous Substances Data)

Usage

Chemical structure

A complex chemical compound with a spirocyclic structure.

Functional groups

Contains a dicarboxylic acid ester, a methyl group, and a phenylmethyl group.

Applications

Potential use in the pharmaceutical industry as a building block for the synthesis of novel drugs or as a research tool in medicinal chemistry.

Reactivity

The spirocyclic nature of the compound gives it unique properties and reactivity, making it a valuable target for chemical synthesis and study.

Complexity

The presence of both a methyl and phenylmethyl substituent adds further complexity and potential for diverse applications in organic chemistry.

Upstream product

• 928030-26-6 benzoyl chloroformate 
• 172967-13-4 methyl 1,4-dioxa-8-azaspiro[4,5]decane-6-carboxylate 
• 140176-27-8 1-oxo-1,3-piperidinedicarboxylic acid 1-benzyl ester 3-methyl ester 
• 107-21-1 ethylene glycol 

Relevant articles and documents

SUBSTITUTED-QUINOXALINE-TYPE-PIPERIDINE COMPOUNDS AND THE USES THEREOF

The invention relates to Substituted-Quinoxaline-Type Piperidine Compounds, compositions comprising an effective amount of a Substituted-Quinoxaline-Type Piperidine Compound and methods to treat or prevent a condition, such as pain, comprising administeri

Methods for inhibiting protein kinases

The present invention provides methods for inhibiting protein kinases selected from the group consisting of AKT, Checkpoint kinase, Aurora kinase, Pim kinases, and tyrosine kinase using pyrazolo[1,5-a]pyrimidine compounds and methods of treatment, prevent

Heterocyclic analgesic compounds and methods of use thereof

One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.

Heterocyclic analgesic compounds and methods of use thereof

One aspect of the present invention relates to novel heterocyclic compounds. A second aspect of the present invention relates to the use of the novel heterocyclic compounds as ligands for various cellular receptors, including opiate receptors, other G-protein-coupled receptors, and ion channels. An additional aspect of the present invention relates to the use of the novel heterocyclic compounds as analgesics.